Glyconogenesis (glyco- + synthesis + genesis) is the process of glycogen biosynthesis from carbohydrate components of the cell. This is an important process for all living organisms, including humans, since glucose is the main source of energy for cells.
Glycerol (ethylene glycol) is an important metabolite for many organisms and animals. It plays a key role in glycolysis and gluconeogenesis. Glycolysis is the reaction of the breakdown of glycogen into glucose, while gluconeogenesis is the reaction of the synthesis of glucose from carbon components of the body.
Normal cell volume is so dependent on glycogen content that during treatment one can expect that the total effect of increasing the volume of one cell corresponds to the action of glucagon, a hormone that stimulates the production of glycogen by liver cells and, consequently, the rest of the body. The less glucagon (glyconeogenic) material glycogen is in the body or the less sensitive the liver is to glucagon, the smaller the tissue volume. This is especially observed in renal failure (including congestive).
The amount of sugar directly depends on the glycemic level. If the glucose concentration exceeds 5.2 mmol/L, then glycogenolysis is accelerated due to the activation of certain protein chains of glucose-6-phosphate (all effects occur only at glucose concentration levels greater than 5.7 mmol/L). And if the glucose level is below 5.1 mmol/liter and always remains less than 4.8 mmol/liter within 15 minutes after the start of the test, then the amount of glycogen in the cellular substance decreases so much that it is as if the entire glycogen reserve is burned out.